Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentationSushila A. Toulmin, Laurence C. Eisenlohr, Jeremy Katzen et al.|Nature Communications|2021Cited by 63
Type II alveolar cells with constitutive expression of MHCII and limited antigen presentation capacity contribute to improved respiratory viral disease outcomesSushila A. Toulmin, Laurence C. Eisenlohr, Chaitali Bhadiadra et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1